Stock image for illustration purposes only - book cover, edition or condition may vary.
Medicines and Risk/Benefit Decisions
. Ed(S): Walker, S.R.; Asscher, W.
€ 61.53
FREE Delivery in Ireland
Description for Medicines and Risk/Benefit Decisions
Paperback. Editor(s): Walker, S.R.; Asscher, W. Series: CMR Workshop Series. Num Pages: 165 pages, biography. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 234 x 156 x 10. Weight in Grams: 290.
The third CMR Workshop prov. ided the opportunity for a group of experts from the Industry, academia and the regulatory authorities to meet and discuss ways and means by which risk benefit decisions are made during the various stages of drug development. It became apparent from the discussions that took place in October 1985, at the CIBA Foundation, that decisions are often made with limited data and inadequate methodology. The conclusions drawn from the day's deliberations were as follows: 1. Current methodology for assessing risk and particularly benefits must be improved; 2. Safety must be assessed in association with benefits ... Read more
The third CMR Workshop prov. ided the opportunity for a group of experts from the Industry, academia and the regulatory authorities to meet and discuss ways and means by which risk benefit decisions are made during the various stages of drug development. It became apparent from the discussions that took place in October 1985, at the CIBA Foundation, that decisions are often made with limited data and inadequate methodology. The conclusions drawn from the day's deliberations were as follows: 1. Current methodology for assessing risk and particularly benefits must be improved; 2. Safety must be assessed in association with benefits ... Read more
Product Details
Format
Paperback
Publication date
2011
Publisher
Springer Netherlands
Number of pages
165
Condition
New
Series
CMR Workshop Series
Number of Pages
165
Place of Publication
Dordrecht, Netherlands
ISBN
9789401079464
SKU
V9789401079464
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Medicines and Risk/Benefit Decisions